Recent blog posts
Advances in Clinical Research on Cholinesterase Inhibitors
Advances in Clinical Research on Cholinesterase Inhibitors
27 September 2023
Cholinesterase is a class of glycoprotein that is present in the body in various isoenzyme forms. It can be generally divided into true cholinesterase and pseudocholinesterase.
Read →
The Body's Inflammatory Messengers: COX-2 Inhibitors
The Body's Inflammatory Messengers: COX-2 Inhibitors
26 September 2023
Cyclooxygenase, also known as Prostaglandin-endoperoxide Synthase, is a bifunctional enzyme with both cyclooxygenase and peroxidase activity.
Read →
Advances in Clinical Research on CYP2D6 inhibitor
Advances in Clinical Research on CYP2D6 inhibitor
26 September 2023
The CYP2D6 gene encodes the CYP2D6 enzyme, which is a crucial member of the cytochrome P450 system, a crucial enzyme in the metabolism of various drugs.
Read →
Analysis on the Clinical Research Progress of cholesterol drug
Analysis on the Clinical Research Progress of cholesterol drug
26 September 2023
Cholesterol, also known as cholesterin, is a derivative of polycyclic hydrocarbon, widely present in animal bodies, especially abundant in brain and neural tissues.
Read →
Analysis on the Research Progress of IL-6 inhibitors
Analysis on the Research Progress of IL-6 inhibitors
26 September 2023
Interleukin-6 (IL-6) is a 26-kDa secretory protein composed of 184 amino acids and two N-glycosylation sites, as well as four cysteine residues in the mature IL-6.
Read →
Progress and Challenges in Targeted Cancer Metabolic Drugs - IDH2 inhibitors
Progress and Challenges in Targeted Cancer Metabolic Drugs - IDH2 inhibitors
26 September 2023
IDH2, or isocitrate dehydrogenase 2, is an enzyme that plays a crucial role in cellular metabolism.
Read →
New approach to cancer treatment-MDM2 inhibitors
New approach to cancer treatment-MDM2 inhibitors
25 September 2023
MDM2 is a crucial protein found in the human body that plays a significant role in regulating cell growth and division.
Read →
Advances in Clinical Research on Mcl-1 Inhibitors
Advances in Clinical Research on Mcl-1 Inhibitors
25 September 2023
Mcl-1, also known as myeloid cell leukemia-1, is a protein that plays a crucial role in regulating cell survival and apoptosis (programmed cell death) in the human body.
Read →
Progress of IL-17A Inhibitors in the Treatment of Autoimmune and Inflammatory Diseases
Progress of IL-17A Inhibitors in the Treatment of Autoimmune and Inflammatory Diseases
25 September 2023
IL-17A, or Interleukin-17A, is a cytokine that plays a crucial role in the human body's immune response.
Read →
Analysis on the Clinical Research Progress of IL-23 inhibitors
Analysis on the Clinical Research Progress of IL-23 inhibitors
22 September 2023
IL-23, or Interleukin-23, is a crucial cytokine that plays a significant role in the human body's immune response.
Read →
Analysis on the Clinical Research Progress of MAO-B inhibitors
Analysis on the Clinical Research Progress of MAO-B inhibitors
22 September 2023
Monoamine oxidase-B (MAO-B) is an enzyme found in the human body that plays a crucial role in the metabolism of neurotransmitters such as dopamine.
Read →
New Treatment Option for Inflammatory Diseases - IRAK4 inhibitors
New Treatment Option for Inflammatory Diseases - IRAK4 inhibitors
22 September 2023
Interleukin-1 receptor-associated kinases (IRAKs) were initially identified as serine/threonine kinases that can bind to the interleukin-1 receptor (IL-1R) upon induction by the pro-inflammatory cytokine interleukin-1 (IL-1).
Read →